Structure Therapeutics earnings were -$143.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest GPCR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$46.8M, up 28.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GPCR reported annual earnings of -$122.5M, with 36.7% growth. The next GPCR earnings date is Aug 7, 2025.
Structure Therapeutics Earnings Reports & History FAQ
What were Structure Therapeutics's earnings last quarter?
Structure Therapeutics (NASDAQ: GPCR) reported Q1 2025 earnings per share (EPS) of -$0.81, up 42.11% year over year. Total GPCR earnings for the quarter were -$46.83 million. In the same quarter last year, Structure Therapeutics's earnings per share (EPS) was -$0.57.
The next GPCR earnings call is Invalid Date. Add GPCR to your watchlist to be reminded of Structure Therapeutics's next earnings date.
Is Structure Therapeutics profitable or losing money?
As of the last Structure Therapeutics earnings report, Structure Therapeutics is currently losing money. Structure Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$143.32 million, a 46.73% increase year over year.
What was GPCR's earnings growth in the past year?
As of Structure Therapeutics's earnings date in Q3 2025, Structure Therapeutics's earnings has grown year over year. GPCR earnings in the past year totalled -$143.32 million.
What are Structure Therapeutics's earnings expectations?
The current EPS estimate for Structure Therapeutics's earnings report in Invalid Date is -$0.26.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.